Barely Significant
← all excerpts

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

Transl Med UniSa · 2016 · PMC4912339 · PMID 27326396

Europe PMC
1
hedged sentence
0.0051
closest p · 0.1× alpha
0.0051
boldest claim

The sentences

highly significantp= 0.0051actually significant
These meta-analyses substantially confirmed a reduction of bleeding, without a significant reduction of mortality rate in patients treated with bivalirudin; however a re-evaluation of current data adding MATRIX study patients demonstrate for the first time highly significant benefits of radial access in acute coronary syndrome patients for major adverse cardiovascular events (p= 0.0051) and all-cause mortality (p= 0.0011) in patients treated with bivalirudin 19 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.